Skip to content

Comparing remimazolam with propofol on postoperative quality of recovery in patients undergoing ambulatory arthroscopic surgery

Comparing remimazolam with propofol on postoperative quality of recovery in patients undergoing ambulatory arthroscopic surgery

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053014
Enrollment
Unknown
Registered
2021-11-09
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee joint disease

Interventions

Group R(remimazolam group):Induction and maintenance of remazolam anesthesia
Group P( propofol group):Induction and maintenance of propofol anesthesia

Sponsors

The First Affiliated Hospital of Anhui Medical Univercity
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Patients under general anesthesia for elective unilateral arthroscopic surgery, aged 18 to 64 years, regardless of gender, BMI:18-30 kg/m^2, normal communication, ASA grade I-II, and voluntary subjects signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe cardiopulmonary disease; 2. Endocrine system diseases: pituitary tumor, severe diabetes, hypercortisol syndrome, pheochromocytoma, etc.; 3. Mental and psychological diseases: such as schizophrenia, depression, history of chronic analgesic drug use, history of alcoholism, opioid dependence; 4. Parkinson's disease, history of cerebral infarction, Alzheimer's disease, severe insomnia; 5. Inability to understand the visual analogue scale (VAS) and the 15-item Quality of Recovery (QoR-15) after surgery; 6. The preoperative life cannot take care of oneself; 7. Those with a history of bleeding disorders or abnormal coagulation function.

Design outcomes

Primary

MeasureTime frame
15-item Quality of Recovery,QoR-15;

Secondary

MeasureTime frame
Athens Insomnia Scale;Recovery time;Orientation recovery time;Ramsay sedative score;Bispectral index;hemodynamic parameters;Adverse reaction;

Countries

China

Contacts

Public ContactTang Lili

The First Affiliated Hospital of Anhui Medical Univercity

tanglilys@163.com+86 18654110160

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026